Low-Grade Glioma, NOS
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (2) HC (2) | BRAF p.V600E | Low-Grade Glioma, NOS | Dabrafenib, Trametinib | |
| FDA (1) | BRAF rearrangements | Low-Grade Glioma, NOS | Tovorafenib | |
| FDA (1) | v::BRAF | Low-Grade Glioma, NOS | Tovorafenib | |
| FDA (1) | BRAF p.V600E | Low-Grade Glioma, NOS | Tovorafenib | |
| FDA (1) | BRAF p.V600K | Low-Grade Glioma, NOS | Tovorafenib |